Episurf Medical present at Aktiedagen, held in Malmö on September 27

Episurf Medical (NASDAQ: EPIS B) will present at Aktiedagen, an investor conference held in Malmö (Kockum Fritid, Hörsalen) on September 27. The event is arranged by Aktiespararna and the company will be represented by CEO Pål Ryfors.

For full program and registration, see link. (https://www.aktiespararna.se/aktiviteter/aktiedagen-malmo-0)

The presentation will be available on the company’s website.

For more  information, please contact:

Pål Ryfors, CEO, Episurf Medical

Tel:+46 (0) 709 62 36 69

Email: pal.ryfors@episurf.com

About Episurf Medical

Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.